Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,335,208
-
Share change
-
+26,230
-
Total reported value
-
$517,620
-
Price per share
-
$0.16
-
Number of holders
-
24
-
Value change
-
-$2,856,560
-
Number of buys
-
15
-
Number of sells
-
15
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q3 2022
As of 30 Sep 2022,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,335,208 shares.
The largest 10 holders included
ACADIAN ASSET MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, Telemetry Investments, L.L.C., MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, GROUP ONE TRADING, L.P., JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, SIMPLEX TRADING, LLC, and Virtu Financial LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.